Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04491370
Title Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors New York Medical College
Indications

Hodgkin's lymphoma

marginal zone B-cell lymphoma

mantle cell lymphoma

Burkitt lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Polatuzumab vedotin-piiq

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.